Beam Therapeutics Inc. (BEAM) vs Liquidia Corporation (LQDA)
A side-by-side comparison of Beam Therapeutics Inc. and Liquidia Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BEAM
Beam Therapeutics Inc.
$25.18HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
LQDA
Liquidia Corporation
$26.26HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — BEAM vs LQDA
growth of $100 · dividends reinvested · last 7yBEAM +36.9% (+4.6%/yr)LQDA +341.9% (+23.6%/yr)LQDA compounded faster over this window
BEAM LQDA
BEAM vs LQDA: by the numbers
- •BEAM is the larger company ($2.59B vs $2.34B market cap).
- •LQDA is profitable (30.74% net margin) while BEAM runs a net loss (-54.75%).
- •BEAM grew revenue faster over the past five years (479.04% vs 128.77% CAGR).
Metrics side by side
Valuation
| Metric | BEAM | LQDA |
|---|---|---|
| P/E ratio | N/A | 19.18 |
| Forward P/E | N/A | 10.57 |
| P/S ratio | 16.60 | 5.18 |
| P/B ratio | 2.43 | 11.97 |
| EV / EBITDA | N/A | 12.81 |
| FCF yield | N/A | 2.59% |
Profitability
| Metric | BEAM | LQDA |
|---|---|---|
| Gross margin | 84.05% | 92.48% |
| Operating margin | -274.57% | -32.45% |
| Net margin | -54.75% | 30.74% |
| ROE | -8.00% | 71.04% |
| ROIC | -28.96% | 46.99% |
Growth (annualized)
| Metric | BEAM | LQDA |
|---|---|---|
| Revenue CAGR (5Y) | 479.04% | 128.77% |
| Total return CAGR (5Y) | -21.41% | 59.01% |
Frequently asked
- Which has grown faster, BEAM or LQDA?
- Over the past five years, BEAM grew revenue faster — BEAM at a 479.04% CAGR versus LQDA at 128.77%.
- Is BEAM or LQDA more profitable?
- LQDA runs the higher net margin — BEAM at -54.75% versus LQDA at 30.74%.
- How have BEAM and LQDA total returns compared?
- Over the past 5 years, BEAM delivered -21.41% and LQDA delivered 59.01% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Liquidia P/E ratioBeam Therapeutics ROELiquidia ROEBeam Therapeutics operating marginLiquidia operating marginBeam Therapeutics revenue growthLiquidia revenue growthBeam Therapeutics free cash flowLiquidia free cash flow
Beam Therapeutics & Liquidia appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.